KRAS G12C inhibitor 30 is a selective inhibitor targeting the KRAS G12C mutation. This compound demonstrates significant anti-tumor activity by disrupting the downstream signaling pathways associated with oncogenic KRAS. It is primarily utilized in cancer research, particularly in studies focused on therapies for KRAS-driven malignancies.
KRAS G12C inhibitor 30 is a selective inhibitor targeting the KRAS G12C mutation. This compound demonstrates significant anti-tumor activity by disrupting the downstream signaling pathways associated with oncogenic KRAS. It is primarily utilized in cancer research, particularly in studies focused on therapies for KRAS-driven malignancies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
